Steris Plc(STE) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | S&P 500 | P/E | 27.93 | EPS (ttm) | 8.18 | Insider Own | 0.34% | Shs Outstand | 97.5M | Perf Week | 1.47% |
| Market Cap | 22.28B | Forward P/E | 18.63 | EPS next Y | 9.35% | Insider Trans | -3.32% | Shs Float | 97.2M | Perf Month | 8.29% |
| Enterprise Value | 23.85B | PEG | 1.92 | EPS next Q | 2.68 | Inst Own | 100.08% | Short Float | 2.47% | Perf Quarter | -2.7% |
| Income | 0.81B | P/S | 3.69 | EPS this Y | 10.27% | Inst Trans | -0.11% | Short Ratio | 3.41 | Perf Half Y | 3.98% |
| Sales | 6.04B | P/B | 3.09 | EPS next 5Y | 9.69% | ROA | 7.62% | Short Interest | 2.40M | Perf YTD | -9.87% |
| Book/sh | 73.91 | P/C | 46.19 | EPS past 3/5Y | 95.07% 11.37% | ROE | 11.37% | 52W High | -15.2% ($269.44) | Perf Year | -5.16% |
| Cash/sh | 4.95 | P/FCF | 24.07 | Sales past 3/5Y | 9.38% 13.82% | ROIC | 8.97% | 52W Low | 17.09% ($195.14) | Perf 3Y | 9.12% |
| Dividend Est. | $2.68 (1.17%) | EV/EBITDA | 14.24 | EPS Y/Y TTM | 23.94% | Gross Margin | 45% | Volatility(W/M) | 2.55% 2.18% | Perf 5Y | -1.56% |
| Dividend TTM | 2.58 | EV/Sales | 3.95 | Sales Y/Y TTM | 8.37% | Oper. Margin | 19.61% | ATR (14) | 5.02 | Perf 10Y | 241.44% |
| Dividend Ex-Date | 2026/9/4 | Quick Ratio | 1.35 | EPS Q/Q | 13.83% | Profit Margin | 13.34% | RSI (14) | 61.77 | Recom | 2 |
| Dividend Gr. 3/5Y | 10.16% 9.4% | Current Ratio | 1.91 | Sales Q/Q | 7.3% | SMA20 | 4.45% ($218.76) | Beta | 0.87 | Target Price | $263.5 |
| Payout | 31.04% | Debt/Eq | 0.28 | Earnings | 2026/11/4 | SMA50 | 3.78% ($220.17) | Rel Volume | 0.65 | Prev Close | $230.12 |
| Employees | 17937 | LT Debt/Eq | 0.24 | EPS/Sales Surpr. | 3.82% 0.34% | SMA200 | 1.46% ($225.2) | Avg Volume(3M) | 0.70M | Price | $228.49 |
| IPO | 1992/6/1 | Option/Short | Yes/Yes | Trades | 9330 | Volume | 459,587 | Change | -0.71% |
🏥 STERIS (STE) is a global medical equipment company that comprehensively provides essential infection prevention solutions, sterilization equipment, and operating room devices to hospitals, surgery centers, pharmaceutical companies, and life science research laboratories worldwide.
Over the past 1 year, roughly in the middle
15% below its 1-year high.
Traded less than usual. That is 65% of its average volume.
Next earnings report: November 4
7 days to go.
STE makes money exceptionally well
Of every $100 in sales, $19.61 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +10.3% this year.
Tap to view numbers
The price is about the industry average
For a company earning $100 a year, you would pay $2,793. Peers typically go for $2,793. Compared with its own 5-year average, it is 41% cheaper now.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -1.6%. The S&P 500 did +70% over the same period.
Tap to view numbers
The dividend is on the small side
Pays 1.17% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 100.1%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
IHI iShares U.S. Medical Devices ETF 0.03% 
CSMD Congress SMid Growth ETF 0.02% 
DOCK Corgi Ports, Rail & Freight ETF 0.02% 
MDEV First Trust Indxx Medical Devices ETF 0.02% 
POWA Invesco Bloomberg Pricing Power ETF 0.02% Special products that amplify (leveraged) or invert this single stock. They decay quickly and are not for long-term holding.
SLX VanEck Steel ETF 150M It ranks #9 of 142 in the industry
Based on market cap of $22B.
FAQ
What kind of company is STE?
STE belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of STE?
The market cap of STE is approximately $22.3B, ranking 563 within its sector.
Does STE pay dividends?
STE has a dividend yield of approximately 1.17%, with an annual dividend of $2.68.
What is the P/E ratio of STE?
STE has a P/E ratio of approximately 27.9x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for STE?
STE has recorded a 52-week high of $269.44 and a low of $195.14.
